Status:
COMPLETED
Study in Healthy Adult Female Subjects
Lead Sponsor:
InventisBio Co., Ltd
Conditions:
Mass Balance Recovery
Eligibility:
FEMALE
18-65 years
Phase:
PHASE1
Brief Summary
An Open Label Phase 1 Study in Healthy Adult Female Subjects to Determine the Mass Balance Recovery, Absorption, Metabolism, and Excretion of \[14C\] D-0502 Following Single Oral Dose Administration
Eligibility Criteria
Inclusion
- Healthy adult female volunteers not of child-bearing potential between the ages of 18 and 65. Other inclusion criteria will be reviewed by the Principal Investigator.
Exclusion
- History or presence of any condition or prior surgery that, in the opinion of the Investigator, poses a significant risk to subject safety and/or achievement of study objectives
- Clinically significant abnormal medical history, or any abnormal findings on physical examination, vital signs, ECG, or laboratory tests
- Other exclusion criteria will be reviewed by the Principal Investigator.
Key Trial Info
Start Date :
March 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT05339633
Start Date
March 29 2022
End Date
October 31 2022
Last Update
April 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Site Location
Baltimore, Maryland, United States, 21201